Generic Name: Eculizumab
Brand Name: Soliris
Manufacturer: Alexion Pharma Canada
Therapeutic Area: Atypical hemolytic uremic syndrome
Indications: Hemolytic Uremic Syndrome, Atypical
Submission Type: Request For Advice
Project Status: Complete
CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Eculizumab
Brand Name: Soliris
Manufacturer: Alexion Pharma Canada
Therapeutic Area: Atypical hemolytic uremic syndrome
Indications: Hemolytic Uremic Syndrome, Atypical
Submission Type: Request For Advice
Project Status: Complete